iSpecimen Inc. (ISPC) Financial Statements (2024 and earlier)

Company Profile

Business Address 450 BEDFORD STREET
LEXINGTON, MA 02420
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 8731 - Commercial Physical and Biological Research (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments5,0065,6638,21411,02215,30920,658
Cash and cash equivalents2,3442,7222,0053,76315,30920,658
Short-term investments2,6622,9416,2097,259  
Receivables2,9413,1312,5574,5903,9263,096
Other undisclosed current assets292333200348441482
Total current assets:8,2399,12710,97115,96019,67624,236
Noncurrent Assets
Operating lease, right-of-use asset194234107146185223
Property, plant and equipment12814616419522619
Intangible assets, net (including goodwill)908     
Intangible assets, net (excluding goodwill)908     
Other noncurrent assets  213    
Other undisclosed noncurrent assets6,3516,5766,3285,6384,5313,462
Total noncurrent assets:7,5817,1696,5995,9794,9423,704
TOTAL ASSETS:15,81916,29517,57021,93924,61827,940
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5,4663,3082,6623,6103,9901,861
Interest and dividends payable8
Accounts payable3,9252,2801,7802,7012,459968
Accrued liabilities1,5411,0288829081,531886
Deferred revenue416479098132 
Debt      817
Other undisclosed current liabilities167162108147158156
Total current liabilities:6,0493,5172,8603,8554,2812,833
Noncurrent Liabilities
Long-term debt and lease obligation:      68
Liabilities, other than long-term debt 2972  27 
Operating lease, liability 2972  2768
Other undisclosed noncurrent liabilities      2,547
Total noncurrent liabilities: 2972  272,683
Total liabilities:6,0783,5892,8603,8554,3085,516
Equity
Equity, attributable to parent9,74112,70614,71118,08420,30922,423
Common stock111111
Treasury stock, value(0)(0)(0)(0)(0)(0)
Additional paid in capital69,10468,99668,89068,76268,57468,528
Accumulated other comprehensive income11119  
Accumulated deficit(59,365)(56,292)(54,181)(50,697)(48,265)(46,106)
Total equity:9,74112,70614,71118,08420,30922,423
TOTAL LIABILITIES AND EQUITY:15,81916,29517,57021,93924,61827,940

Income Statement (P&L) ($ in thousands)

3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
Revenues2,5752,7781,6252,9502,9622,583
Cost of revenue(1,319)(2,972)(2,451)(2,126)(1,280)(2,617)
Cost of goods and services sold(1,427)(1,393)(854)(1,147)(1,410)(1,182)
Gross profit:1,256(194)(826)8241,682(34)
Operating expenses(4,127)(2,000)(2,736)(3,367)(3,823)(3,068)
Operating loss:(2,871)(2,194)(3,562)(2,542)(2,142)(3,101)
Nonoperating income (expense)(202)8378111(18)5
Other nonoperating income (expense)(30)20(29)(0) 3
Interest and debt expense(4)(4)(4)(4)(100)(59)
Loss from continuing operations:(3,077)(2,116)(3,487)(2,435)(2,260)(3,154)
Loss before gain (loss) on sale of properties:(3,154)
Net loss:(3,077)(2,116)(3,487)(2,435)(2,260)(3,154)
Other undisclosed net income attributable to parent444410059
Net loss available to common stockholders, diluted:(3,073)(2,111)(3,484)(2,432)(2,160)(3,096)

Comprehensive Income ($ in thousands)

3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
Net loss:(3,077)(2,116)(3,487)(2,435)(2,260)(3,154)
Other comprehensive income (loss)0(0)(18)19  
Comprehensive loss:(3,077)(2,116)(3,505)(2,417)(2,260)(3,154)
Comprehensive loss, net of tax, attributable to noncontrolling interest  (2,111)(3,502)(2,413)  
Other undisclosed comprehensive income, net of tax, attributable to parent8,042     
Comprehensive income (loss), net of tax, attributable to parent:4,965(4,227)(7,007)(4,829)(2,260)(3,154)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: